Viewing Study NCT06339008


Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-02-03 @ 1:49 PM
Study NCT ID: NCT06339008
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2024-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Perennial Allergic Rhinitis (PAR) View
Keywords: